This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aaronson KD, Schwartz JS, Chen TMC, Wong KL, Goin JE, Mancini DM (1997) Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 95:2660–2667.
Abbustini E, Dal-Bello B, Morbini P (1997) Factors increasing the risk of allograft vascular disease in heart transplant recipients. G Ital Cardiol 27:985–999.
Addonizio LJ, Rose EA (1987) Cardiac transplantation in children and adolescents. J Pediatr 111:1034–1038.
Alderman EL, Litwin P, Fisher LD, Kaiser GC, Myers WO, Maynard C, Levine F, Schloss M (1983) Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 68:785–795.
Andersson R, Sandberg T, Berglin E, Jeansson S (1992) Cytomegalovirus infections and toxoplasmosis in heart transplant recipients in Sweden. Scand J Infect Dis 24:411–417.
Anguita M, Arizon JM, Balles F (1992) Influence on survival after heart transplantation of contraindications seen in transplant recipients. J Heart Lung Transplant 11:708–715.
Arbustini E, Grasso M, Diegoli M, Percivalle E, Grossi P, Bramerio M, Campana C, Goggi C, Gavazzi A, Vigano M (1992) Histopathologic and molecular profile of human cytomegalovirus infections in patients with heart transplants. Am J Clin Pathol 98:205–213.
Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio-JJ J, Olsen EG, Schoen FJ (1987) Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1:3–14.
Aretz HT (1987) Myocarditis: the Dallas criteria. Hum pathol 18:619–624.
Armitage JM, Kormos RL, Fung J, Starzl TE (1992) The clinical trial of FK 506 as primary and rescue immunosuppression in adult cardiac transplantation. Ann Thor Surg 54:205–211.
Armstrong AT, Strauch AR, Kardan A, Starling RC (1996) Morphometric and immunocytochemical analysis of coronary arterioles in human transplanted hearts. J Heart Lung Transplant 15:818–826.
Asfour B, Weyand M, Kececioglu D, Kehl HG, Hammel D, Loick M, Vogt J, Scheid HH (1997) A novel paracorporeal mechanical assist device for newborns and infants allows bridging to transplantation. Transplant Proc 29:3330–3332.
Avery RK (1998) Prevention and treatment of cytomegalovirus infection and disease in heart transplant recipients. Curr Opin Cardiol 13:122–129.
Baba HA, Schmid KW, Schmid C, Blasius S, Heinecke A, Kerber S, Scheid HH, Bocker W, Deng MC (1998) Possible relationship between heat shock protein 70, cardiac hemodynamics, and survival in the early period after heart transplantation. Transplantation 65:799–804.
Baba HA, Schmid C, Wilhelm MJ, Blasius S, Scheid HH, Bocker W, Dockhorn DB (1997) Inducible heat shock protein 70 in rat cardiac allograft and its immuno-histochemical localization in cardiac myocytes. Transplantation 64:1035–1040.
Backman SB, Ralley FE, Fox GS (1993) Neostigmine produces bradycardia in a heart transplant patient. Anesthesiology 78:777–779.
Bailey LL, Nehlsen-Cannarella SL, Doroshow RW, Jacobson JG (1986) Cardiac allotransplantation in newborns as therapy for hypoplastic left heart syndrome. N Engl J Med 315:949–951.
Bailey LL, Gundry SR (1990) Hypoplastic left heart syndrome. Pediatr Clin North Am 37:137–150.
Bailey LL, Gundry SR, Razzouk A, Wang N (1992) Pediatric heart transplantation: issues relating to outcome and results. J Heart Lung Transplant 11:267–271.
Bailey LL, Gundry SR, Razzouk A, Wang N, Sciolaro C, Chivelli M (1993) Bless the babies: one hundred fifteen late survivors of heart transplantation during the first year of life. J Thorac Cardiovasc Surg 105:805–814.
Ballester M, Obrador D, Carrio I, Auge JM, Moya C, Pons-Llado G, Carlps-Riera JM (1990) Indium-111-monoclonal antimyosin antibody studies after the first year of heart transplantation. Identification of risk groups for developing rejection during longterm follow-up and clinical implications. Circulation 82:2100–2107.
Ballester M, Obrador D, Carrio I (1992) Early postoperative reduction of monoclonal antimyosin antibody uptake is associated with absent rejection-related complications after heart transplantation. Circulation 85:61–68.
Baraldi-Junkins C, Levin HR, Kasper EK, Rayburn BK, Herskowitz A, Baughman KL (1993) Complications of endomyocardial biopsy in heart transplant patients. J Heart Lung Transplant 12:63–67.
Barr ML, Meiser BM, Eisen HJ, Roberts RF, Livi U, Dall’Amico R, Dorent R, Rogers JG, Radovancevic B, Taylor DO, Jeevanandam V, Marboe CC (1998) Photophoresis for the prevention of rejection in cardiac transplantation. N Engl J Med 339:1744–1751.
Barr ML, Sanchez JA, Seche LA, Schulman LL, Smith CR, Rose EA (1990) Anti-CD3 monoclonal antibody induction therapy. Immunological equivalency with triple-drug therapy in heart transplantation. Circulation 82 (suppl IV):291–294.
Batista R (1999) Partial left ventriculectomy — the Batista procedure. Eur J Cardiothorac Surg 15 (Suppl 1):S 9–12.
Batista RJ, Verde J, Nery P, Bocchino L, Takeshita N, Bhayana JN, Bergsland J, Graham S, Houck JP, Salerno TA (1997) Partial left ventriculectomy to treat end-stage heart disease. Ann Thorac Surg 64(3):634–638.
Baum D, Bernstein D, Stranes VA, Oyer P, Pitlick P, Stinson E, Shumway N (1991) Pediatric Heart Transplantation at Stanford: results of a 15-year experience. Pediatrics 88:203–214.
Bengel F, Ueberfuhr P, Ziegler S, Nekolla S, Reichart B, Schwaiger M (1999) Serial assessment of sympathetic reinnervation after orthotopic heart transplantation. A longitudinal study using PET and C-11 hydroxyephedrine. Circulation 99:1866–1871.
Beniaminovitz A, Itescu S, Lietz K, Donovan M, Burke EM, Groff BD, Edwards N, Mancini DM (2000) Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. N Engl J Med 342:613–619.
Bennett WM, Porter GA (1988) Cyclosporine-associated hypertension. Am J Med 85:131–133.
Bernstein D, Baum D, Berry G, Dahl G, Weiss L, Starnes VA (1993) Neoplastic disorders after pediatric heart transplantation. Circulation 88:230–237.
Billingham ME, Cary NRB, Hammond ME, Kemnitz J, Marboe C, McAllister HA, Snovar DC, Winters GL, Zerbe A (1990) A working formulation for the standardisation of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Lung Transplant 9:587–593.
Billingham ME (1982) Diagnosis of cardiac rejection by endomyocardial biopsy. J Heart Transplant 1:25–30.
Billingham ME (1985) Endomyocardial biopsy detection of acute rejection in cardiac allograft recipients. Heart Vessels Suppl 1:86–90.
Billingham ME (1987) Cardiac transplant atherosclerosis. Transplant Proc 19:19–25.
Billingham ME (1988) The postsurgical heart. The pathology of cardiac transplantation. Am J Cardiovasc Pathol 1:319–334.
Billingham ME (1992) Histopathology of graft coronary disease. J Heart Lung Transplant 11:38–44.
Billingham ME (1994) Pathology and etiology of chronic rejection of the heart. Clin Transplant 8:289–292.
Birovljev S, Radovancevic B, Burnett CM (1992) Heart transplantation after mechanical circulatory support: Four years experience. J Heart Lung Transplant 11:240–245.
Boiling SF, Pagani FD, Deeb GM, Bach DS (1998) Intermediate-term outcome of mitral reconstruction in cardiomyopathy. J Thorac Cardiovasc Surg 115(2):381–386.
Borow KM, Neumann BS, Arensman FW (1985) Left ventricular contractility and contractile reserve in humans after cardiac transplantation. Circulation 71: 866–872.
Boucek MM (1995) Pediatric heart transplantation. Curr Opin Cardiol 10:223–238.
Bourge RC, Kirklin JK, Naftel DC, Figg WD, White-Williams C (1991) Diltiazemcyclosporine interaction in cardiac transplant patients: impact on cyclosporine dose and medication costs. Am J Med 90:402–403.
Bouthot BA, Murthy BV, Schmid CH, Leviey AS, Pereira BJ (1997) Longterm follow-up of hepatitis C virus infection among organ transplant recipients. Transplantation 63:849–853.
Bove EL, Stammers AH (1986) Recovery of left ventricular function after hypothermic global ischemia. Age-related differences in the isolated working rabbit heart. J Thorac Cardiovasc Surg 91:115–122.
Branch KR, Dembitsky WP, Peterson KL, Adamson R, Gordon JB, Smith SC Jr, Jaski BE (1994) Physiology of the native heart and Thermo Cardiosystems left ventricular assist device complex at rest and during exercise: implications for chronic support. J Heart Lung Transplant 13:641–651.
Braunwald E (ed) (1992) Heart disease. A textbook of cardiovascular medicine. Saunders, Philadelphia.
Breithardt G (1995) Amiodarone in patients with heart failure (editorial). N Engl J Med 333:121–122.
Brunken RC, Mody FV, Hawkins RA, Nienaber C, Phelps ME, Schelbert HR (1992) Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201 Tl defects. Circulation 86:1357–1369.
Bunzel B (1994) Psychosoziale Aspekte der Herztransplantation und Lebensqualitätsmessung. Thieme, Stuttgart.
Burow RD, Strauss HW, Singleton R et al. (1977) Analysis of left ventricular function from multiple gated acquisition cardiac blood pool imaging. Comparison to contrast angiography. Circulation 56:1024–1028.
Butman SM, Wild JC, Nolan PE, Fagan TC, Finley PR, Hicks MJ, Mackie MJ, Copeland JG (1991) Prospective study of safety and financial benefit of ketokonazole as adjunct therapy to cyclosporine A after heart transplantation. J Heart Lung Transplant 10:351–358.
Caforio AL, Keeling PJ, Zachara E, Mestroni L, Camerini F, Mann JM, Bottazzo GF, McKenna WJ (1994) Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 344:773–777.
Carrio I, Berna L, Ballester M (1988) Indium-111 antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J Nucl Med 29:1893–1900.
Castaneda AR, Jonas RA, Mayer JE, Hanley FL (1994) Cardiac Surgery of the Neonate and Infant. WB Saunders, Philadelphia.
Caves P, Stinson E, Billingham M, Rider A, Shumway N (1973) Diagnosis of human cardiac rejection by serial cardiac biopsy. J Thorac Cardiovasc Surg 66:461–466.
Cetta F, O’Leary PW, Seward JB, Driscoll DJ (1995) Idiopathic restrictive cardiomyopathy in childhood: diagnostic features and clinical course. Mayo Clin Proc 70:634–640.
Chadburn A, Cesarman E, Knowles DM (1997) Molecular pathology of posttransplantation lymphoproliferative disorders. Semin Diagn Pathol 14:15–26.
Chakko S, de Nadena E, Kessler K, Myerburg R (1989) Ventricular arrhythmias in congestive heart failure. Clin Cardiol 12:525–530.
Chan L, Schrier RW (1990) Effects of calcium channel blockers on renal function. Ann Rev Med 41:289–302.
Chatenoud L, Bach JF (1990) Monoclonal antibodies to CD3 as immunosuppressants. Semin Immunol 2:437–447.
Chen SC, Nouri S, Balfour I, Jureidini S, Appleton RS (1990) Clinical profile of congestive cardiomyopathy in children. St. Louis University School of Medicine, Department of Pediatrics, Cardinal Glennon Children’s Hospital, Missouri 63104. J Am Coll Cardiol 15:189–193.
Cherry R, Nielsen H, Reed E (1992) Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulation anti-HLA antibodies. J Heart Lung Transplant 11:24–30.
Chiu RC, Bindon W (1987) Why are newborn hearts vulnerable to global ischemia? The lactate hypothesis. Circulation 76:V 146–149.
Christopherson LK (1987) Cardiac transplantation: a psychological perspective. Circulation 75:57–62.
CIBIS Investigators and Committees (1994) A randomized trial of β-blockade in heart failure: the Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 90:1765–1773.
Ciliberto GR, Mangiavacchi M, Banfi F (1993) Coronary artery disease after heart transplantation: non-invasive evaluation with excercise thallium scintigraphy. Eur Heart J 14:226–229.
Clark NJ, Martin RD (1988) Anesthetic considerations for patients undergoing cardiac transplantation. J Cardiothorac Anesth 2:519–542.
Cleland JGF, Dargie HJ, Ford I (1987) Mortality in heart failure: clinical variables of prognostic value. Br Heart J 58:572–582.
Codoner-French P, Bernard O, Alvarez F (1993) Long-term follow-up of growth in height after successful liver transplantation. J Pediatr 124:368–373.
Cohn JN, Levine B, Olivari MT, Garberg V, Lura D, Francis GS, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with congestive heart failure. N Engl J Med 311:819–823.
Cohn JN, Rector TS (1988) Prognosis of congestive heart failure and predictors of mortality. Am J Cardiol 62: A-30 A.
Cohn JN (1986) Effect of vasodilator therapy on mortality in chronic congestive heart failure. N Engl J Med 314:1547–1552.
Cohn JN (1991) A comparison of enalapril with hydralazine-isosorbide-dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325:303–310.
Connors AF, Speroff T, Dawson NV (1996) The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA 276:889–897.
Consensus Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 316:1429–1435.
Costanzo-Nordin MR, Winters GL, Fisher SG, O’Sullivan J, Heroux AL, Kao W, Mullen GM, Johnson MR (1993) Endocardial infiltrates in the transplanted heart: clinical significance emerging from the analysis of 5026 endomyocardial biopsy specimens [see comments]. J Heart Lung Transplant 12:741–747.
Cooley DA, Liotta D, Hallman GL, Bloodwell RD, Leachman RD, Milam JD (1969) Orthotopic cardiac prosthesis for two-staged cardiac replacement. Am J Cardiol 24:723–730.
Copeland JG, Emery RW, Levinson MM, Icenogle TB, Carrier M, Ott RA, Copeland JA, McAleer-Rhenman MJ, Nicholson SM (1987) Selection of patients for cardiac transplantation. Circulation 75:1–9.
Corno AF, Bethencourt DM, Laks H, Haas GS, Bhuta S, Davtyan HG, Flynn WM, Drinkwater DC, Laidig C, Chang P (1987) Myocardial protection in the neonatal heart. A comparison of topical hypothermia and crystalloid and blood cardioplegic solutions. J Thorac Cardiovasc Surg 93:163–172.
Corper CI, Jones PH, Suki WN (1988) Rhabdomyolysis and renal injury with lovastatin use. JAMA 260:239–241.
Costanzo-Nordin MR, Grusk DB, Silver MA, Sobotka PA, Winters GL, O’Connell JB, Pifarre R, Robinson JA (1988) Reversal of recalcitrant cardiac allograft rejection with methotrexate. Circulation 78 (suppl III):47–57.
Costanzo-Nordin MR, O’Sullivan EJ, Johnson MR, Winters GL, Pifarre R, Radvany R, Zucker MJ, Scanlon PJ, Robinson JA (1990) Prospective randomized trial of OCT3 vs. horse antithymocyte globulin based immunosuppressive prophylaxis in heart transplantation. J Heart Transplant 9:306–315.
Dae MW, De Marco T, Botvinick EH (1992) Scintigraphic assessment of MIBG uptake in globally denervated human and canine hearts — implications for clinical studies. J Nucl Med 33:1444–1450.
Dec GW, Semigran MJ, Vlahakes GJ (1991) Cardiac transplantation: current indications and limitations. Transplant Proc 23:2095–2106.
DEFIBRILAT Study Group (1991) Actuarial risk of sudden death while awaiting cardiac transplantation in patients with atherosclerotic heart disease. Am J Cardiol 68:545–546.
Deiwick M, Hamann PA, Weyand M, Deng MC, Möllhoff T, Budde T, Scheid HH (1994) Heterotope Herztransplantation — eine Alternative in der Therapie der terminalen Herzinsuffizienz. Tx Med 6:262–269.
Deiwick M, Löhrer A, Hoffmeier A, Baba HA, Böcker W, Scheid HH (1999) Postoperative death should be followed by autopsy — an analysis of the autopsy findings of the year 1990 and 1991 in a heart surgery center. Thorac Cardiovasc Surg 47:82–87.
Deng MC (1992) Pathophysiologie der chronischen Herzinsuffizienz. In: Park JW (Hrsg) Therapie der chronischen Herzinsuffizienz. Pabst-Verlag, Lengerich.
Deng MC, Tjan TDT, Asfour B, Gradaus R, Böcker D, Loick HM, Baba HA, Breithardt G, Scheid HH, Borggrefe M, Hammel D (1999) Combining non-pharmacological therapies for advanced heart failure: the Muenster experience with the assist device — defibrillator combination. Am J Cardiol 83:158 D-160 D.
Deng MC, DeMeester J, Scheid HH (1999) Development of cardiac transplant policy in Germany (editorial part 1). Thorac Cardiovasc Surgeon 47:1–4.
Deng MC, Weyand M, Hammel D, Schmid C, Kerber S, Schmidt C, Breithardt G, Scheid HH (1998) Selection and outcome of ventricular assist device patients: the Muenster experience. J Heart Lung Transplant 17:817–825.
Deng MC (für die Arbeitsgruppe Thorakale Organtransplantation der DGK), Angermann CE, Beyersdorf F, Dengler TJ, Geiger A, Haaf B, Haverich A, Mohacsi P, Permanetter B, Pethig K, Scheidt W, Wahlers T, Weis M, Welz A, Zerkowski HR, Zimmermann R (1996) Indikationen, Kontraindikationen und differentialtherapeutische Alternativen der Herztransplantation. Derzeitiger Stand und Ergebnisse einer Umfrage bei deutschen Transplantationsprogrammen. Z Kardiol 85:519–527.
Deng MC, Breithardt G, Scheid HH (1995) Interdisciplinary Heart Failure and Transplant Program Münster: A 5-Year Experience. Int J Cardiol 50:7–17.
Deng MC, Erren M, Lütgen A, Zimmermann P, Brisse B, Schmitz W, Assmann G, Breithardt G, Scheid HH (1996) Interleukin-6 correlates with hemodynamic impairment during dobutamine administration in chronic heart failure. Int J Cardiol 57:129–134.
Deng MC, Gradaus R, Weyand M, Rahmel A, Hammel D, Hoffmeier A, Frye K, Günther F, Kerber S, Block M, Breithardt G, Scheid HH (1995) Retrospective comparison of survival patterns in subgroups of patients referred for cardiac transplantation: the ABC-relationship. Tx Med 7:53–57.
Deng MC, Gradaus R, Weyand M, Hammel D, Günther F, Kerber S, Block M, Haverkamp W, Roeder N, Breithardt G, Scheid HH (1996) Heart transplant candidates at high risk can be identified at the time of initial evaluation. Transplant Int 9:38–45.
Deng MC, Erren M, Tamminga N, Tjan TDT, Werntze B, Zimmermann P, Weyand M, Hammel D, Möllhoff T, Scheid HH (1999) Left ventricular assist system support is associated with persistent inflammation and temporary immunosuppression. Thorac Cardiovasc Surg 47(suppl):326–331.
Deng MC, Erren M, Roeder N, Dreimann V, Günther F, Kerber S, Baba HA, Schmidt C, Breithardt G, Scheid HH (1998) T-cell and monocyte subsets, inflammatory molecules, rejection and hemodynamics early after cardiac transplantation. Transplantation 65:1255–1261.
Deng MC, Drees G, Scheid HH (1996) Ethische Aspekte der Herztransplantation. In: Quante M, Ach JS (Hrsg) Ethische Probleme der Organtransplantation. Universitätsverlag, Münster.
Deng MC, Mennewisch A, Artmann F, Bloching B, Kerber S, Breithardt G, Scheid HH (1996) Improved Spiroergometric Exercise Capacity 26 Months after Cardiac Transplantation Compared to End Stage Chronic Heart Failure. Tx Med 8:128–131.
Deng MC, Wilhelm M, Scheid HH (1998) Effects of exercise during long-term support with a left ventricular assist device. Circulation 97:1212–1213.
Deng MC, Wilhelm M, Weyand M, Hammel D, Kerber S, Breithardt G, Scheid HH (1997) Long-term left ventricular assist device support: a novel pump rate challenge exercise protocol to monitor native left ventricular function. J Heart Lung Transplant 16:629–635.
DeVries WC (1988) The permanent artificial heart: four case reports. JAMA 259:849–859.
DiBiase A, Tse T, Schnittger I, Wexler L, Stinson EB, Valantine HA (1991) Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers. Am J Cardiol 67:1385–1389.
Dillon T, Sullivan M, Schatzlein M (1991) Cardiac transplantation in patients with treated malignancies. Transplantation 52:82–85.
Dor V (1990) Surgery for left ventricular aneurysm. Curr Opin Cardiol 5(6):773–780.
Dor V, Sabatier M, Montiglio F, Coste P, Di Donato M (1999) Endoventricular patch reconstruction in large ischemic wall-motion abnormalities. J Card Surg 14(1):46–52.
Dor V, Sabatier M, Di Donato M, Montiglio F, Toso A, Maioli M (1998) Efficacy of endoventricular patch plasty in large postinfarction akinetic scar and severe left ventricular dysfunction: comparison with a series of large dyskinetic scars. J Thorac Cardiovasc Surg 116(1):50–59.
Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman GR, Curiel R (1994) Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 344:493–498.
Drees G, Scheid HH (1991) Herztransplantation — ethische und juristische Aspekte. In: Toellner R (Hrsg) Jahrbuch des Arbeitskreises Medizinischer Ethik-Kommissionen in der Bundesrepublik Deutschland. Fischer Verlag, Stuttgart.
Drees H, Scheid HH (1993) Psychosoziale Aspekte der Herztransplantation. Z Tx Med 5:143–146.
Dummer JS, Ho M, Simmons RL (1995) Infections in solid organ transplant recipients. In: Mandell GL, Douglas RG, Bennett JE (eds) Principles and Practice of Infectious Diseases. Churchill Livingstone, New York, pp 2722–2732.
Dunn MJ, Glassroth J (1989) Pulmonary complications of amiodarone toxicity. Prog Cardiovasc Dis 31:447.
Dunn MJ, Crisp SJ, Rose ML, Taylor PM, Yacoub MH (1992) Anti-endothelial antibodies and coronary artery disease after cardiac transplantation. Lancet 339:1566–1570.
Edwalds GM, Said JW, Block MI, Herscher LL, Siegel RJ, Fishbein MC (1984) Myocytolysis (vacuolar degeneration) of myocardium: immunohistochemical evidence of viability. Hum Pathol 15:753–756.
Edwards BS, Rodeheffer RJ (1992) Prognostic features in patients with congestive heart failure and selection criteria for cardiac transplantation. Mayo Clin Proc 67:485–492.
El-Banayosi A, Deng MC, Loisance DY, Vetter H, Gronda E, Loebe M, Vigano M (1999) The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study. Eur J Cardiothor Surg 15:835–884.
Ensley RD, Hunt SA, Taylor DO (1992) Predictors of survival after repeat heart transplantation. J Heart Lung Transplant 11:142–158.
Farrar DJ, Thoratec Ventricular Assist Device Principal Investigators (1994) Pre-operative predictors of survival in patients with Thoratec ventricular assist devices as a bridge to heart transplantation. J Heart Lung Transplant 13:93–101.
Farrar DJ, Lawson JH, Litwak P, Cederwall G (1990) Thoratec VAD system as a bridge to heart transplantation. J Heart Transplant 9:415–423.
Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH (1982) NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 97:78–92.
Fisch RD, Nabel EG, Selwyn AP (1988) Responses of coronary arteries of cardiac transplant patients of acetylcholine. J Clin Invest 81:21–31.
Fishbein MC, Bell G, Lones MA, Czer LS, Miller JM, Harasty D, Trento A (1994) Grade 2 cellular heart rejection: does it exist? [see comments]. J Heart Lung Transplant 13:1051–1057.
Fishman JA, Rubin RH, Koziel MJ, Pereira BJ (1997) Hepatitis C virus and organ transplantation. Transplantation 62:147–154.
Follansbee WP, Kiernan JM, Curtiss El, Zerbe TR, Mock C, Kormos RL (1991) Changes in left ventricular systolic function that accompany rejection of the transplanted heart: a serial radionuclide assessment of fifty-three consecutive cases. Am Heart J 121:548–556.
Fragomeni LS, Kaye MP (1988) The Registry of the International Society for Heart and Lung Transplantation: Fifth official report — 1988. J Heart Lung Transplant 7:249–253.
Franciosa JA (1987) Why patients with heart failure die: hemodynamic and functional determinants of survival. Circulation 75 (suppl IV):20–27.
Frazier OH, Macris MP, Myers TJ, Duncan JM, Radovancevic B, Parnis SM, Cooley DA (1994) Improved survival after extended bridge to cardiac transplantation. Ann Thorac Surg 57:1416–1422.
Freeman AM, Watts D, Karp R (1984) Evaluation of cardiac transplant candidates. Psychiatr Med 6:8–22.
Fricker FJ, Addonizio L, Bernstein D (1999) Heart transplantation in children. Indications. Pediatr Transplantation 3:333–342.
Friedman RA, Moak JP, Garson A Jr (1991) Clinical course of idiopathic dilated cardiomyopathy in children. J Am Coll Cariol 18:152–156.
Friedman WF (1972) Neuropharmacologic studies of perinatal myocardium. Cardiovasc Clin 4:43–57.
Frierson RL, Lippmann SB (1987) Heart transplant patients rejected on psychiatric indication. Psychosomatics 28:347–355.
Gallino A, Maggiorini M, Kiowski W, Martin X, Wunderli W, Schneider J, Turina M, Follath F (1996) Toxoplasmosis in heart transplant recipients. Eur J Clin Microbiol Infect Dis 15:389–393.
Gamberg P, Miller JL, Lough ME (1987) Impact of protective isolation on the incidence of infection after heart transplantation. J Heart Transplant 6:147–149.
Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA (1988) Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 12:334–340.
Gaudin PB, Rayburn BK, Hutchins GM, Kasper EK, Baughman KL, Goodman SN, Lecks LE, Baumgartner WA, Hruban RH (1994) Peritransplant injury to the myocardium associated with the development of accelerated arteriosclerosis in heart transplant recipients [see comments]. Am J Surg Pathol 18:338–346.
Georgiev VS (ed) (1989) Infectious Diseases in the Immunocompromised Hosts. CRC Press, Boca Raton, pp 1201.
Goldstein DJ, Seldomridge JA, Addonizio LL, Rose EY, Oz MC, Michler RE (1995) Orthotopic heart transplantation in patients with treated malignancies. Am J Cardiol 75:968–971.
Gottlieb SS, Kukin ML, Ahern D, Packer M (1989) Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol 13:1534.
Gradman A, Deedwania P, Cody R (1989) Predictors of total mortality and sudden death in mild to moderate heart failure. J Am Coll Cardiol 14:564–570.
Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE (1989) Cytomegaly-virus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 261:3561–3566.
Griffin ML, Hernandez A, Martin TC, Goldring D, Bolman RM, Spray TL, Strauss AW (1988) Dilated cardiomyopathy in infants and children. J Am Coll Cardiol 11:139–144.
Griffiths PD (1997) Prophylaxis against CMV infection in transplant patients. J Antimicrob Chemother 39:299–301.
Günther F, Deng MC, Rahmel A, Kerber S, Frye K, Scheid HH, Breithardt G (1995) Der herztransplantierte Patient in der Nachsorge. Medwelt 46:202–210.
Gulizia JM, Kandolf R, Kendall TJ, Thieszen SL, Wilson JE, Radio SJ, Costanzo MR, Winters GL, Miller LL, McManus BM (1995) Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts. Am J Pathol 147:461–475.
Gürtner C, Klepzig H Jr, Lelbach S (1994) Sympathetic reinnervation following heart transplantation — a double-tracer study with 123I-MIBG and 201T1. Nuklearmedizin 33:106–112.
Haberl R, Weber M, Reichen-Spurner H (1987) Frequency analysis of surface electrogram for recognition of acute rejection after orthotopic cardiac transplantation in man. Circulation 76:101–108.
Hajjar DP, Falcone DJ, Fowler S, Minick CR (1981) Endothelium modifies the altered metabolism of the injured aortic wall. Am J Pathol 102:28–39.
Hall TS, Baumgartner WA, Borkon AM (1986) Diagnosis of acute cardiac rejection with antimyosin monoclonal antibody, phosphorous nuclear magnetic resonance imaging, two-dimensional echocardiography, and endomyocardial biopsy. J Heart Transplant 5:419–424.
Halle AA, Wilson RF, Massin EK (1992) Coronary angioplasty in cardiac transplant patients: results of a multicenter study. Circulation 86:458–462.
Hammel D, Tjan TDT, Scheid HH, Schmid C, Loick M, Deng MC (1998) Successful treatment of a Novacor LVAD malfunction without repeat sternotomy. Thorac Cardiovasc Surg 46:154–156.
Hammer C, Reichenspurner H, Ertl W (1984) Cytological and immunological monitoring of cyclosporine-treated human heart recipients. J Heart Transplant 3:228–232.
Hammond EH, Yowell RL, Nunoda S, Menlove RL, Renlund DG, Bristow MR, Gay WAJ, Jones KW, O’Connell JB (1989) Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant 8:430–443.
Hanster V, Oeding M, Deng MC (1993) Krankengymnastische Aspekte bei Kreislaufunterstützung und Herztransplantation. Z Tx Med 5:140–142.
Haraldson A, Kieler-Jensen N, Nathorst-Westfelt U, Bergh CH, Ricksten SE (1998) Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Chest 114:780–786.
Haraldson A, Kieler-Jensen N, Ricksten SE (1996) Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. J Cardiothorac Vasc Anesth 10:864–868.
Hardesty RL, Griffith BP, Trento A (1986) Mortally ill patients and excellent survival following cardiac transplantation. Ann Thorac Surg 41:126–129.
Hartmann A, Maul FD, Huth A (1993) Serial evaluation of left ventricular function by radionuclide ventriculography at rest and during exercise after orthotopic heart transplantation. Eur J Nucl Med 20:146–150.
Hausmann H, Warnecke H, Ennker J, Topp H, Schiessler A, Hempel B, Friedel N, Schmitt D, Hetzer R (1993) Survival predictors in patients with a left ventricular ejection fraction of 10–30% receiving a coronary bypass: analysis of preoperative variables. Cardiovasc Surg 1:558–562.
Haverty TP, Sanders M, Sheahan M (1993) OKT3 treatment of cardiac allograft rejection. J Heart Lung Transplant 12:591–598.
Hehrlein FW, Netz H, Moosdorf R, Dapper F, Scheid HH, Bauer J, Boldt J (1991) Pediatric heart transplantation for congenital heart disease and cardiomyopathy. Ann Thorac Surg 52:112–117.
Henderson G (1977) Coping behavior after shipwreck. Br J Psychiatr 131:15–20.
Hensley FA Jr, Martin DE, Larach DR (1987) Anesthetic management for cardiac transplantation in North America — 1986 Survey. J Cardiothorac Anesth 1:429–437.
Herrmann M, Weyand M, Greshake B von EC, Proctor RA, Scheid HH, Peters G (1997) Left ventricular assist device infection is associated with increased mortality but is not a contraindication to transplantation. Circulation 95:814–817.
Herrmann G, Haverich A, Ziemer G, Luhmer I, Kallfelz HC, Borst HG (1988) Orthotope Herztransplantation im Kinder-und Jugendalter. Monatsschr Kinderheilkd 136:327–330.
Hesse A, Altland K, Linke RP, Almeida MR, Saraiva MJ, Steinmetz A, Maisch B (1993) Cardiac amyloidosis: a review and report of a new transthyretin (prealbumin) variant. Br Heart J 70:111–115.
Hesse B, Mortensen S, Folke M, Brodersen AK, Aldershvile J, Pettersson G (1995) Ability of antimyosin scintigraphy monitoring to exclude acute rejection during the first year after heart transplantation. J Heart Lung Transplant 14:23–31.
Hess N, Brooks-Brunn JA, Clark D, Joy K (1985) Complete isolation: is it necessary? J Heart Transplant 4:458–459.
Hill JD (1993) Proceedings of the circulatory support 1991 STS Symposium 1991: Part III: Infections-prophylaxis and treatment. Ann Thorac Surg 55:217–221.
Ho M, Dummer JS (1995) Infections in transplant recipients. In: Mandell GL, Douglas RG, Bennett JE (eds) Principles and Practice of Infectious Diseases. Churchill Livingstone, New York, pp 2709–2717.
Ho KKL, Anderson KM, Kannel WB, Grossman W, Levy D (1993) Survival after the onset of congestive heart failure in Framingham heart study subjects. Circulation 88:107–115.
Hoffmeier A, Schmid C, Deng MC, Weyand M, Kerber S, Schmidt C, Scheid HH (1996) Multiple cardiac procedures after heart transplantation: a case report. Thorac Cardiovasc Surgeon 44:216–221.
Honkonen EL, Kaukinen L, Pekkonen EJ, Luipalla P (1998) Dopexamine unloads the impaired right ventricle better than iloprost a prostacyclin analog after coronary artery surgery. J Cardiothorac Vasc Anesth 12:647–653.
Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ (1998) The Registry of the International Society for Heart and Lung Transplantation: fifteenth official report — 1998. J Heart Lung Transplant 17(7):656–668.
Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ (1999) The Registry of the International Society for Heart and Lung Transplantation: Sixteenth Official Report 1999. J Heart Lung Transplant 18:611–626.
Hosenpud JD, Breen TJ, Edwards EB, Daily OP, Hunsicker LG (1994) The effect of transplant center volume on cardiac transplant outcome. A report of the United Network for Organ Sharing Scientific Registry. JAMA 271:1844–1849.
Houston SH, Rubin RH, Sinnott JT (1996) Infections in transplantation. In: Reese RE, Betts RF (eds) A Practical Approach to Infectious Diseases. Little Brown, Boston, pp 785–811.
Hruban RH, Beschorner WE, Baumgartner WA, Augustine SM, Ren H, Reitz BA, Hutchins GM (1990) Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis. Am J Pathol 137:871–882.
Hsu DT, Garofano RP, Douglas JM, Michler RE, Quaegebeur JM, Gersony WM, Addonizio LJ (1993) Exercise performance after pediatric heart transplantation. Circulation 88 (part 2):238–242.
Hummel M, Thalmann U, Jautzke G, Staib F, Seibold M, Hetzer R (1992) Fungal infections following heart transplantation. Mycoses 35:23–34.
Hunt SA (1993) 24th Bethesda Conference: Cardiac Transplantation. JACC 22/1:1–64.
Ino T, Benson LN, Freedom RM, Rowe RD (1988) Natural history and prognostic risk factors in endocardial fibroelastosis. Am J Cardiol 62 (7):431–434.
Institute of Medicine, Washington, DC (1991) In: Hogness JR, Van Antwerp M (eds) The artificial heart: prototypes, policies, and patients. National Academic Press.
Isobe M, Sekiguchi M (1996) Staging of cardiac rejection by simultaneous administration of 123I-antimyosin and 111 In-anti MHC class II antibodies. Acta Cardiol 51:515–520.
Jautzke G, Sell M, Thalmann U, Janitschke K, Gottschalk J, Schurmann D, Ruf B (1993) Extracerebral toxoplasmosis in AIDS. Histological and immunohistological findings based on 80 autopsy cases. Pathol Res Pract 189:428–436.
Jett GK, Miller A, Savino D, Gonwa T (1992) Reversal of acute fulminant lymphocytic myocarditis with combined technology of OKT3 monoclonal antibody and mechanical circulatory support. J Heart Lung Transplant 11:733–738.
Johnson DE, Alderman EL, Schroeder JS (1991) Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J Am Coll Cardiol 17:449–457.
Johnson MR (1992) Transplant coronary disease: nonimmunologic risk factors. J Heart Lung Transplant 11:124–132.
Johnston A, Holt DW (1993) External quality assessment scheme for cyclosporine in body fluids. Scand J Clin Invest 53:48–53.
Joshi A, Masek MA, Brown BW Jr, Weiss LM, Billingham ME (1995) “Quilty” revisited: a 10-year perspective. Hum Pathol 26:547–557.
Joyce LD, Johnson KE, Pierce WS (1986) Summary of the word experience with clinical use of total artificial hearts as heart support devices. J Heart Transplant 5:229–235.
Kahan BD (1989) Cyclosporine. N Engl J Med 321:1725–1738.
Kahan BD, Shaw LM, Holt DW, Grevel J, Johnston A (1990) A consensus document: Hawk’s Cay meeting on therapeutic drug monitoring of cyclosporine. Clin Chem 36:1510–1516.
Kappler J, Ziesche S, Nelson J (1986) Reproducibility of hemodynamic and gas exchange data during exercise in patients with stable congestive heart failure. Heart Failure 4:157–163.
Kasper EK, Agema WR, Hutchins GM, Deckers JW, Hare JM, Baughman KL (1994) The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 23:586–590.
Katritsis D, Wilmshurst PT, Wendon JA, Davies MJ, Webb PM (1991) Primary restrictive cardiomyopathy: clinical and pathologic characteristics. J Am Coll Cardiol 18:1230–1235.
Kavanagh T (1991) Exercise training in patients after heart transplantation. Herz 16:243.
Kavanagh T, Yacoub MH, Campbell RB, Mertens DJ (1986) Marathon running after cardiac transplantation: a case history. J Cardiopulmonary Rehabil 6:16.
Kavanagh T, Yacoub MH, Mertens DJ, Kennedy J, Campbell RB, Sawyer P (1988) Cardiorespiratory responses to exercise traning after orthotopic cardiac transplantation. Circulation 77:162–171.
Kaye DM, Thompson J, Jennings A (1993) Cyclosporine therapy after cardiac transplantation causes hypertension and renal vasoconstriction without sympathetic activation. Circulation 88:1101–1109.
Kennedy JI, Myers JL, Plumb VJ, Fulmer JD (1987) Amiodarone pulmonary toxicity: clinical, radiologic, and pathologic correlations. Arch Intern Med 147:50–55.
Keogh AM, MacDonald P, Mundy J, Chang V, Harvison A, Pratt P (1992) Five-year follow-up of a randomized double-drug versus triple-drug therapy immunosuppressive trial after heart transplantation. J Heart Lung Transplant 11:550–556.
Keogh A, Spratt P, McCosker C, MacDonald P, Mundy J, Kaan A (1995) Ketoconazole to reduce the need for cyclosporine after cardiac transplantation. N Engl J Med 333:628–633.
Keogh AM, Baron DW, Hickie JB (1990) Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 65:903–908.
Keogh AM, Freund J, Baron DW, Hickie JB (1988) Timing of cardiac transplantation in idiopathic dilated cardiomyopathy. Am J Cardiol 61:418–422.
Kerber S, Rahmel A, Heinemann-Vechtel O, Budde T, Block M, Deng MC, Scheid HH, Breithardt G (1995) Angiographie intravascular ultrasound and functional findings early after orthotopic heart transplantation. Int J Cardiol 49:119–129.
Kerber S, Heinemann-Vechtel O, Günther F, Rahmel A, Block M, Weyand M, Deng MC, Scheid HH, Breithardt G (1996) Intravaskulär-sonographische Koronargefäßbefunde nach orthotoper Herztransplantation: Vergleich zu klinischen Faktoren. Herz 21:320–329.
Kerber S, Puskas C, Jonas M, Janssen F, Heinemann-Vechtel O, Kosch M, Deng MC, Schober O, Scheid HH, Breithardt G (1996) Can Tl-201 myocardial SPECT abnormalities in orthotopic heart recipients be explained by diffuse coronary vessel wall alterations assessed by intravascular ultrasound? Int J Cardiol 57:91–96i.
Kieler-Jensen N, Lundin S, Ricksten SE (1995) Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin El, and sodium nitroprusside. J Heart Lung Transplant 14:436–443.
Kieler-Jensen N, Milocco I, Ricksten SE (1993) Pulmonary vasodilation after heart transplantation. A comparison among prostacyclin, sodium nitropruside, and nitroglycerin on right ventricular function and pulmonary selectivity. J Heart Lung Transplant 12:179–184.
Kirklin JK, Naftel DC, McGiffin DC, McVay RF, Blackstone EH, Karp RB (1988) Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol 11:917–924.
Kirklin JK, Hiraoka Y, Barratt-Boyes BG (1993) Cardiac surgery (2nd ed). Churchill Livingstone, New York.
Kishimoto C, Kuroki Y, Ochiai H, Kurokawa M, Sasayama S (1994) Cytokine and murine coxsackievirus B3 myocarditis. Interleukin-2 suppressed myocarditis in the acute stage but enhanced the condition in the subsequent stage. Circulation 89:2836–2842.
Klanke D, Hammer C, Schubel C, Caca C, Dirschedl P, Gokel M, Kemkes BM (1989) Reproducibility and reliability of cytoimmunological monitoring (CIM) of heart transplanted patients (HTP). Transplant Proc 21:2512–2513.
Knowles DM, Cesarman E, Chadburn A, Frizzera G, Chen J, Rose EA, Michler RE (1995) Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood 85:552–565.
Kobashigawa J, Miller L, Renlund D, Mentzer R, Alderman E, Bourge R, Costanzo M, Eisen H, Dureau G, Ratkovec R, Hummel M, Ipe D, Johnson J, Keogh A, Mamelok R, Mancini D, Smart F, Valantine H (1998) A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Transplantation 66:507–515.
Kobashigawa JA, Kirklin JK, Naftel DC, Bourge RC, Ventura HO, Mohanty PK, Cintron GB, Bhat G, White-Williams C, Caddell G, Waits E, Tarkka M, Nomberg R, Smith D, Finklea J, Holmes P, Veazey M, Sims P, Wallace P (1993) Pretransplantation risk factors for acute rejection after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 12:355–366.
Kobashigawa JA, Stevenson LW, Brownfield E, Moriguchi JD, Kawata N, Hamilton M, Minkely R, Drinkwater DC, Laks H (1993) Does short course induction with OKT3 improve outcome after cardiac transplantation? A randomized trial. J Heart Lung Transplant 12:205–208.
Kondruweit M, Schmid C, Janssen F, Kerber S, Deng MC, Peters PE, Schlegel W, Scheid HH (1996) ICTP, ein Marker zur Diagnose der Osteoporose nach Herztransplantation. Tx Med 8:125–127.
Kormos RL, Herland DB, Armitage JM, Stein K, Kaufman C, Zeevi A, Duquesnoy R, Hardesty RL, Griffith BP (1990) Monoclonal versus polyclonal antibody therapy for prophylaxis against rejection after heart transplantation. J Heart Transplant 9:1–9.
Kormos RL, Murali S, Dew MA, Armitage JM, Hardesty RL, Borovetz HS, Griffith BP (1994) Chronic mechanical circulatory support: rehabilitation, low morbidity, and superior survival. Ann Thorac Surg 57:51–58.
Kratochwill C, Schmid S, Koller-Strametz J, Kreiner G, Grabenwöger M, Grimm M, Laufer G, Heinz G (1996) Decrease in pacemaker incidence after orthotopic heart transplantation. Am J Cardiol 77:779–783.
Kriehuber E, Leachman RD, Cokkinos D, Messmer B, Cooley DA (1970) Das Elektrokardiogramm nach Menschenherztransplantationen und nach Implantation eines künstlichen Herzens am Menschen. Z Kreisl Forsch 59:780–805.
Kuhn WF, Davis MH, Lippmann SB (1988) Emotional adjustment to cardiac transplantation. Gen Hosp Psychiatr 10:108–113.
Kushwaha SS, Fallon JT, Fuster V (1997) Restrictive cardiomyopathy [see comments]. N Engl J Med 336:267–276.
Laffel GI, Barnett A, Finkelstein S, Kaye MP (1992) The relationship between experience and outcome in heart transplantation. N Engl J Med 327:1220–1225.
Larocco MT, Burgert SJ (1997) Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation. Clin Microbiol Rev 10:277–297.
Lawin P (Hrsg) (1993) Praxis der Intensivbehandlung (6. Aufl.). Thieme, Stuttgart.
Lee KJ, Wallis JW, Miller TR, Bolman RM (1990) The clinical utility of radionuclide ventriculography in cardiac transplantation. J Nucl Med 31:1933–1939.
Lee PN (1994) Comparison of autopsy, clinical and death certificate diagnosis with particular reference to lung cancer. A review of the published data. APMIS Suppl 45:1–42.
Lee WH, Hamilton MA, Stevenson LW, Moriguchi JD, Fonarow GC, Child JS, Laks H, Waiden JA (1993) Impact of left ventricular cavity size on survival in advanced heart failure. Am J Cardiol 72:672–676.
Lee WH, Packer M (1986) Prognostic importance of serum sodium concentration and its modification by converting-enzyme inhibition in patients with severe chronic heart failure. Circulation 73:257–267.
Levin HR, Chen JM, Oz MC, Catanese KA, Krum H, Goldsmith RL, Packer M, Rose EA (1994) Potential of left ventricular assist devices as outpatient therapy while awaiting transplantation. Ann Thorac Surg 58:1515–1520.
Levine B, Kaiman J, Mayer L, Fillit HM, Packer M (1990) Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323:236–241.
Lewis AB (1992) Clinical profile and outcome of restrictive cardiomyopathy in children. Am Heart J 123:1589–1593.
Lewis AB, Chabot M (1991) Outcome of infants and children with dilated cardiomyopathy. Am J Cardiol 68:365–369.
Lie KI, Lim KL, Schuilenberg RM, David GK, Durrer D (1978) Early identification of patients developing late in-hospital ventricular fibrillation after discharge from the coronary care unit. Am J Cardiol 41:674–677.
Likoff MJ, Chandler SI, Kay HR (1987) Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 59:634–638.
Loebe M, Schüler S, Spiegelsberger S (1990) Cytomegalie-Virus-Infektion und Koronarsklerose nach Herztransplantation. Dt Med Wschr 115:1266–1269.
Loker J, Darragh R, Ensing G, Caldwell R (1994) Echocardiographic analysis of rejection in the infant heart transplant recipient. J Heart Lung Transpl 13:1014–1018.
Maisch B, Schonian U, Hengstenberg C, Herzum M, Hufnagel G, Bethge C, Bittinger A, Neumann K (1994) Immunosuppressive treatment in autoreactive myocarditis — results from a controlled trial. Postgrad Med J 70 (suppl 1):29–34.
Maisch B (1998) Classification of cardiomyopathies according to the WHO/ISFC Task Force — more questions than answers? Einteilung der Kardiomyopathien nach der WHO/ISFC Task Force — Mehr Fragen als Antworten? Med Klin 93:199–209.
Mallat Z, Tedgui A, Fontaliran F, Frank R, Durigon M, Fontaine G (1996) Evidence of apoptosis in arrhythmogenic right ventricular dysplasia [see comments]. N Engl J Med 335:1190–1196.
Mancini DM, Eisen H, Kussmaul W, Mull R, Edmunds LH Jr, Wilson JR (1991) Value of peak oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83:778–783.
Mancini DM, Walter G, Reichek N, Lenskinski R, McCully KK, Mullen JL, Wilson JR (1992) Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure. Circulation 85:1364–1373.
Marchlinski FE, Waxmann HL, Buxton AE, Josephson ME (1983) Sustained ventricular tachyarrhythmias during the early postinfarction period: electrophysiologic findings and prognosis for survival. J Am Coll Cardiol 2:240–250.
Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE (1987) Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med 316:780–789.
Maron BJ, Epstein SE (1979) Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 43:1242–1244.
Maron BJ, Nichols PF, Pickle LW, Wesley YE, Mulvihill JJ (1984) Patterns of inheritance in hypertrophie cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol 53:1087–1094.
Martin AB, Webber SA, Fricker FJ (1994) Acute myocarditis. Rapid diagnosis by PCR in children. Circulation 90:330–339.
Martin WJ, Rosenow EC (1988) Amiodarone pulmonary toxicity. Recognition and pathogenesis. I. Chest 93:1067–1075.
Mason JW, O’Connell JB, Herskowitz A, Rose NR, McNaus BM, Billingham ME, Moon TE (1995) A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators [see comments]. N Engl J Med 333:269–275.
Matsumori A, Shioi T, Yamada T, Matsui S, Sasayama S (1994) Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure. Circulation 89:955–958.
Mayer JE, Perry S, O’Brien P, Perez Atayde A, Jonas RA, Castañeda AR, Parness IA (1990) Orthotopic heart transplantation for complex congenital heart disease. J Thorac Cardiovasc Surg 99:484–492.
McCarthy PM, Portner PM, Tobler HG (1991) Clinical experience with the Novacor assist system: bridge to transplantation and the transition to permanent application. J Thorac Cardiovasc Surg 102:578–587.
McCarthy PM, Sabik JF (1994) Implantable circulatory support devices as a bridge to heart transplantation. Sem Thorac Cardiovasc Surg 6:174–180.
McCarthy PM, James KB, Savage RM, Vargo R, Kendall K, Harasaki H, Hobbs RE, Pashkow FJ, Implantable LVAD Study Group (1994) Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Circulation 90 (part 2):83–86.
McDonald K, Rector TS, Braulin EA, Kubo SH, Olivari MT (1989) Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection [see comments]. Am J Cardiol 64:359–362.
McKee PA, Castelli WP, McNamara PM, Kannel WB (1971) The natural history of heart failure: the Framingham study. N Engl J Med 285:1441–1446.
McKelvie RS, Teo KK, McCartney N, Humen D, Montague T, Yusuf S (1995) Effects of exercise training in patients with congestive heart failure: a critical review. J Am Coll Cardiol 25:789–796.
McKenna WJ, Thiene G, Nava A, Fontaliran F, Blomstrom LC, Fontaine G, Camerini F (1994) Diagnosis of arrhythmogenic right ventricular dysplasia/ cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 71:215–218.
McKhann CF (1969) Primary malignancy in patients undergoing immunosuppression for renal transplantation. Transplantation 8:209–212.
McLaughlin M, Thomas P, Onorato I, Rubinstein A, Oleske J, Nicholas S, Krasinski K, Guigli P, Orenstein W (1988) Live virus vaccines in human immuno-deficiency virus-infected children: a retrospective survey. Pediatrics 82:229–233.
McManus BM, Horley KJ, Wilson JE, Malcom GT, Kendall TJ, Miles RR, Winters GL, Costanzo MR, Miller LL, Radio SJ (1995) Prominence of coronary arterial wall lipids in human heart allografts. Implications for pathogenesis of allograft arteriopathy. Am J Pathol 147:293–308.
Meiser BM, Überfuhr P, Fuchs A, Schmidt D, Pfeiffer M, Paulus D, Schulze C, Wildhirt S, Scheidt WV, Angermann C, Klauss V, Martin S, Reichenspurner H, Kreuzer E, Reichart B (1998) Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection. J Heart Lung Transplant 17(8):782–788.
Merlet P, Mazoyer B, Hittinger L (1993) Assessment of coronary reserve in man: comparison between positron emission tomography with oxygen-15-labeled water and intracoronary Doppler technique. J Nucl Med 34:1899–1904.
Middlekauf HR, Stevenson WG, Stevenson LW (1991) Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients. Circulation 84:40–48.
Miller LW (1990) Treatment of cardiac allograft rejection with intravenous corticosteroids. J Heart Transplant 9:283–287.
Miller LW, Schlant RC, Kobashigawa J, Kubo S, Renlund DG (1993) 24th Bethesda Conference (Task Force 5): Complications. J Am Coll Cardiol 22:41–54.
Miller LW, Naftel DC, Bourge RC, Kirklin JK, Brozena SC, Jarcho J, Hobbs RE, Mills RM, Cardiac Transplant Research Database Group (1994) Infection after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 13:381–393.
Miller LW, Kubo SH, Young JB, Stevenson LW, Loh E, Costanzo MR (1995) Medical management of heart and lung failure and candidate selection: report of the consensus conference on candidate selection for heart transplantation — 1993. J Heart Lung Transplant 14:562–571.
Moriel M, Rozanski A, Klein J, Berman DS, Merz CN (1997) The differing prognostic utility of exercise radionuclide ventriculography in coronary artery disease patients with and without prior myocardial infarction. Int J Card Imaging 13:403–413.
Mosquera DA, Goldman MD (1993) Surgical audit without autopsy: tales of the unexpected. Ann R Coll Surg Engl 75:115–117.
Müller FU, Boknik P, Horst A, Knapp J, Linck B, Schmitz W, Vahlensieck U, Deng MC, Scheid HH (1995) The cAMP response element binding protein (CREB) is expressed and phosphorylated in the human heart (rapid communication). Circulation 92:2041–2043.
Müller J, Warnecke H, Spiegelsberger S, Hummel M, Cohnert T, Hetzer R (1993) Reliable noninvasive rejection diagnosis after heart transplantation in childhood. J Heart Lung Transplant 12:189–198.
Müller J, Wallukat G, Weng YG, Dandel M, Spiegelsberger S, Semrau S, Brandes K, Theodoridis V, Loebe M, Meyer R, Hetzer R (1997) Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy [see comments]. Circulation 96:542–549.
Munger MA, Johnson B, Amber IJ, Callahan KS, Gilbert EM (1996) Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 77:723–727.
Munoz E, Lonquist JL, Radovancevic B (1992) Long-term results in diabetic patients undergoing heart transplantation. J Heart Lung Transplant 11:943–949.
Munoz P, Palomo J, Munoz R, Rodriguez CM, Pelaez T, Bouza E (1995) Tuberculosis in heart transplant recipients. Clin Infect Dis 21:398–402.
Murali S (1999) Mechanical circulatory support with the Novacor LVAS: worldwide clinical results. Thorac Cardiovasc Surg 47 (suppl 2):321–325.
Murali S, Uretsky BF, Armitage JM, Tokarczyk TR, Betschart AR, Kormos RL, Stein KL, Reddy PS, Hardesty RL, Griffith BP (1992) Utility of prostaglandin El in the pretransplantation evaluation of heart failure patients with significant pulmonary hypertension. J Heart Lung Transplant 11:716–723.
Murali S, Uretsky BF, Reddy PS, Tokarczyk TR, Betschart AR (1991) Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents. Am Heart J 122:1375.
Nakanishi T, Jarmakani JM (1984) Developmental changes in myocardial mechanical function and subcellular organelles. Am J Physiol 246:H615–625.
Nakhleh RE, Copenhaver CM, Werdin K, McDonald K, Kubo SH, Strickler JG (1991) Lack of evidence for involvement of Epstein-Barr virus in the development of the “Quilty” lesion of transplanted hearts: an in situ hybridization study. J Heart Lung Transplant 10:504–507.
Narula J, Haider N, Virmani R, DiSalvo TG, Kolodgie FD, Hajjar RJ, Schmidt U, Semigran MJ, Den GW, Khaw BA (1996) Apoptosis in mycocytes in end-stage heart failure [see comments]. N Engl J Med 335:1182–1189.
Nauseef WM, Maki DG (1981) A study of the value of simple protective isolation in patients with granulocytopenia. N Engl J Med 304:448–453.
Nava A, Thiene G, Canciani B, Scognamiglio R, Daliento L, Buja G, Martini B, Stritoni P, Fasoli G (1988) Familial occurrence of right ventricular dysplasia: a study involving nine families. J Am Coll Cardiol 12:1222–1228.
Netz H, Bauer J, Kreuder J, Moosdorf R, Hehrlein FW (1991) Herztransplantation im Kindesalter. Klin Pädiatr 203:72–76.
Netz H, Kreuder J (1994) Probleme nach Herztransplantationen bei Kindern. In: Schmaltz AA, Singer H (Hrsg) Herzoperierte Kinder und Jugendliche (1. Aufl.). Wissenschaftliche Verlagsgesellschaft, Stuttgart.
Neumann DA, Rose NR, Ansari AA, Herskowitz A (1994) Induction of multiple heart autoantibodies in mice with coxsackievirus B3-and cardiac myosin-in-duced autoimmune myocarditis. J Immunol 152:343–350.
Nishioka K, Nakanishi T, George BL, Jarmakani JM (1981) The effect of calcium on the inotropy of catecholamine and paired electrical stimulation in the newborn and adult myocardium. J Mol Cell Cardiol 13:511–520.
Noble S, Faulds D (1998) Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs 56:115–146.
Norman JC, Cooley DA, Kahan BD, Keats AS, Massin EK, Solis RT, Luper WE, Brook MI, Klima T, Frazier OH, Hacker J, Duncan JM, Dasco CC, Winston DS, Reul GJ (1978) Total support of the circulation of a patient with postcardiotomy stone heart syndrome by a partial artificial heart (ALVAD) for 5 days followed by heart and kidney transplantation. Lancet 1:1125–1127.
O’Connell JB, Bourge RC, Costanzo-Nordin MR (1992) Cardiac transplantation: recipient selection, donor procurement, and medical followup. Circulation 86:1061–1079.
O’Connell JB, Renlund DG, Robinson JA (1988) Effect of preoperative hemodynamic support on survival after cardiac transplantation. Circulation 78 (suppl III):78–82.
Oaks TE, Pae WE Jr, Miller CA (1991) Combined registry for the clinical use of mechanical ventricular assist pumps and the total artificial heart in conjunction with heart transplantation: fifth official report — 1990. J Heart Lung Transplant 10:621–625.
Olivari MT, Kubo SH, Braunlin EA, Bolman RM, Ring WS (1990) Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation. Circulation 82:276–280.
Olivari MT, Antolick A, Kaye MP, Jamieson SW, Ring WS (1988) Heart transplantation in elderly patients. J Heart Transplant 7:258–264.
Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di-Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P (1997) Apoptosis in the failing human heart. N Engl J Med 336:1131–1141.
Olson SL, O’Connell JB, Bristow MR, Renlund DG (1990) Methotrexate as an adjunct in the treatment of persistent mild cardiac allograft rejection. Transplantation 50:773–775.
Olson SL, Wagoner LE, Hammond EH, Taylor DO, Yowell RL, Ensley RD, Bristow MR, O’Connell JB, Renlund DG (1993) Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations. J Heart Lung Transplant 12:135–142.
Opelz G, Henderson R (1993) Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients [see comments]. Lancet 342:1514–1516.
Ornish D, Brown S, Scherwitz LW, Billings JH, Armstrong WT, Ports TA, McLanahan SM, Kirkeeide RL, Brand RJ, Gould KL (1990) Can lifestyle changes reverse coronary heart disease? The lifestyle heart trial. Lancet 336:129–133.
Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (for the US Carvedilol Heart Failure Study Group) (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 334:1349–1355.
Packer M, Gottlieb SS, Blum MA (1987) Immediate and longterm pathophysiologic mechanisms underlying the genesis of sudden cardiac death in patients with congestive heart failure. Am J Med 82 (suppl 3 a):4.
Packer M, Lee WH, Kessler PD (1987) Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. Circulation 75 (suppl 4):80.
Packer M (1995) Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure (editorial)? Circulation 92:1379–1382.
Packer M (1995) Prospective randomized amlodipine survival evaluation. Presented at the Annual Meeting of the American College of Cardiology, New Orleans, March 19–22.
Pahl E, Fricker FJ, Trento A, Griffith B, Hardesty R, Gold L, Lawrence K, Beerman L, Fischer D, Neches W (1988) Late follow-up of children after heart transplantation. Transplant Proc XX (suppl 1):743–746.
Pahl E, Zales VR, Fricker FJ, Addonizio LJ (1994) Posttransplant coronary artery disease in children. Circulation 90 (part 2):56–60.
Park JW, Deng MC, Warnecke H, Schüler S, Wirtz JH, Hummel M, Hetzer R, Heinrich KW (1993) Herztransplantationsnachsorge: Probleme im Langzeitverlauf. Dt Ärztebl 90:A 1-724-728.
Park JW, Warnecke H, Deng MC, Schüler S, Heinrich KW, Hetzer R (1992) Early diastolic left ventricular function as a marker of acute cardiac rejection: a prospective serial echocardiographic study. Int J Cardiol 37:351–359.
Parmley WW (1995) Quality of life: do we know what patients want? J Am Coll Cardiol 26:553–554.
Patel R, Paya CV (1997) Infections in solid-organ transplant recipients. Clin Microbiol Rev 10:86–124.
Patel R, Roberts GD, Keating MR, Paya CV (1994) Infections due to nontuberculous mycobacteria in kidney, heart, and liver transplant recipients. Clin Infect Dis 19:263–273.
Patel R, Terasaki PI (1969) Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280:735–739.
Penn I (1978) Malignancies associated with immunosuppressive or cytotoxic therapy. Surgery 83:492–502.
Penn I (1991) The changing pattern of posttransplant malignancies. Transplant Proc 23:1101–1103.
Petzold T, Feindt PR, Kalweit G, Deng MC, Schmid C, Fritz M, Preusse C, Schonfelder B, Kuhn-Regnier F, Schondube F, Gams E (1999) Effects of modification of the allocation system on ischemia duration and costs of heart transplantation. Transplantation Cooperation UNI-NRW. Thorac Cardiovasc Surg 47(3): 153–156.
Pfeffer MA, Stevenson LW (1996) β-adrenergic blockers and survival in heart failure (editorial). N Engl J Med 334:1396–1397.
Pierce WS (1993) Proceedings of the Circulatory Support 1991 STS Symposium 1991. Part IV: Management of secondary dysfunction. Ann Thorac Surg 55:222–226.
Pifarre R, Sullivan H, Montoya A (1992) Comparison of results after heart transplantation: mechanically supported versus nonsupported patients. J Heart Lung Transplant 11:235–239.
Pigott JD, Kouchoukos NJ, Oberman A, Cutter GR (1985) Late results of surgical and medical therapy for patients with coronary artery disease and depressed left ventricular function. J Am Coll Cardiol 5:1036–1045.
Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J (1999) The effect of spironolactone on morbidity and mortality in patients with heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341(10):709–717.
Poirier VL (1999) Worldwide experience with the TCI HeartMate system: issues and future perspective. Thorac Cardiovasc Surgeon 47 (suppl 2):316–320.
Ponticelli C, Rivolta E, Tarantino A, DeVecchi A, Vegeto A (1987) Rescue of severe steroid-resistance rejection with OKT 3. Transplant Proc 19:1908–1909.
Pope SE, Stinson EB, Daughters II GT (1980) Exercise response of the denervated heart in long-term cardiac transplant recipients. Am J Cardiol 46:213–220.
Portner PM, Oyer PE, McGregor CG, Baldwin JC, Ream AK, Wyner J, Zusman DR, Shumway NE (1985) First human use of an electrically powered implantable ventricular assist system (abstr). Artif Organs 9:36.
Portner PM (1993) A totally implantable heart assist system: the Novacor program. In: Akutsu T, Koyanagi H (eds) Heart replacement. Springer, Tokyo.
Pridjian AK, Levitsky S, Krukenkamp I, Silverman NA, Feinberg H (1987) Developmental changes in reperfusion injury. A comparison of intracellular cation accumulation in the newborn, neonatal, and adult heart. J Thorac Cardiovasc Surg 93:428–433.
Pucci A, Ghisetti V, Donegani E, Barbui A, David E, Fortunato M, Papandrea C, Pansini S, Zattera G, di Summa M (1994) Histologic and molecular diagnosis of myocardial human cytomegalovirus infection after heart transplantation. J Heart Lung Transplant 13:1072–1080.
Puskas C, Kosch M, Kerber S (1997) Progressive heterogeneity of myocardial perfusion in heart transplant recipients detected by thallium-201 myocardial SPECT. J Nucl Med 38:760–765.
Quigg RJ, Rocco MB, Gautier DF, Creager MA, Hartley LH, Colucci WS (1989) Mechanism of the attenuated peak heart rate exposure to exercise after orthotopic cardiac transplantation. J Am Coll Cardiol 14:338–344.
Rahmel A, Deng MC, Kerber S, Hoffmeier A, Drees G, Scheid HH, Breithardt G (1994) Herztransplantationsnachsorge: Das Münsteraner Modell. Tx Med 4:270–276.
Ramasamy N, Portner PM (1993) Novacor LVAS: results with bridge to transplant and chronic support (state-of-the-art-review). Cardiac Surg 7:363–376.
Rampazzo A, Nava A, Erne P, Eberhard M, Vian E, Slomp P, Tiso N, Thiene G, Danieli GA (1995) A new locus for arrhythmogenic right ventricular cardiomyopathy (ARVD2) maps to chromosome 1q42-q43. Hum Mol Genet 4:2151–2154.
Redmond JM, Zehr KJ, Gillinov MA, Baughman KL, Augustine SM, Cameron DE, Stuart RS, Acker MA, Gardner TJ, Reitz BA, Baumgartner WA (1993) Use of theophylline for treatment of prolonged sinus node dysfunction in human orthotopic heart transplantation. J Heart Lung Transplant 12:133–139.
Reedy JE, Pennington DG, Miller LW (1992) Status I heart transplant patients: conventional versus ventricular assist device support. J Heart Lung Transplant 11:246–252.
Reedy JE, Swartz MT, Termuhlen DF, Pennington GD, McBride LR, Miller LW, Ruzevich SA (1990) Bridge to transplantation: Importance of patient selection. J Heart Lung Transplant 9:473–481.
Reemtsma K, Berland G, Merrill J (1992) Evaluation of surgical procedures: changing patterns of patient selection and costs in heart transplantation. J Thorac Cardiovasc Surg 104:1308–1313.
Reeves RA, Shapiro AP, Thompson ME (1986) Loss of nocturnal decline in blood pressure after cardiac transplantation. Circulation 73:401–408.
Reichart B, Jamieson SW (1990) Heart and heart-lung transplantation. RS Schulz, München.
Reid R (1989) Pathogenesis and treatment of steroid osteoporosis. Clin Endocrinol 30:83–103.
Reinhardt D (1993) Behandlung mit Glukokortikoiden. In: Reinhardt D (Hrsg) Therapie der Krankheiten im Kindesalter (5. Aufl.). Springer, Berlin Heidelberg New York.
Reitz BA, Baumgartner WA, Oyer PE, Stinson EB (1977) Abdominal aortic aneurysmectomy in longterm cardiac transplant survivors. Arch Surg 112:1057.
Renlund DG, O’Connell JB, Bristow MR (1989) Early rejection prophylaxis in heart transplantation: is cytolytic therapy necessary? J Heart Transplant 8:191–193.
Renlund DG, O’Connell JB, Gilbert EM, Hammond EM, Burton NA, Jones KW, Karwande SV, Doty DB, Menlove RL, Herrick CM (1989) A prospective comparison of murine monoclonal CD 3 (OKT 3) antibody-based and equine antithymocyteglobulin based rejection prophylaxis in cardiac transplantation. Transplantation 47:599–605.
Renlund DG, O’Connell JB, Gilbert EM, Watson FS, Bristow MR (1987) Feasibility of discontinuation of corticosteroid maintainance therapy in heart transplantation. J Heart Transplant 6:71–78.
Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies (1980) Br Heart J 44:672–673.
Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thieme G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93:841–842.
Richtlinien zur Organtransplantation gemäß Paragraph 16 Transplantationsgesetz (2000). Dtsch Ärztebl 97:B 352-B 367.
Rickenbacher PR, Pinto FJ, Chenzbraun A, Botas J, Lewis NP, Alderman EL, Valantine HA, Hunt SA, Schroeder JS, Popp RL (1995) Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound [see comments]. J Am Coll Cardiol 25:171–177.
Rodney RA, Johnson LL (1992) Myocardial perfusion scintigraphy to assess heart transplant vasculopathy. J Heart Lung Transplant 11: S 74–S 78.
Rodney RA, Johnson LL, Blood DK, Barr ML (1994) Myocardial perfusion scintigraphy in heart transplant recipients with and without allograft atherosclerosis: a comparison of thallium-201 and technetium 99m sestamibi. J Heart Lung Transplant 13:173–180.
Romero TE, Friedman WF (1979) Limited left ventricular response to volume overload in the neonatal period: a comparative study with the adult animal. Pediatr Res 13:910–915.
Rose AG, Cooper DK (1996) A histopathologic grading system of hyperacute (humoral, antibody-mediated) cardiac xenograft and allograft rejection. J Heart Lung Transplant 15:804–817.
Rose AG (1997) Cellular and humoral rejection after cardiac transplantation. CVE 2:19–33.
Rose ML, Yacoub MH (1993) Immunology of heart and lung transplantation. Arnold, London.
Rosenbloom M, Laschinger JC, Saffitz JE, Cox JL, Bolman RM III (1989) Non-invasive detection of cardiac allograft rejection by analysis of the unipolar peak-to-peak amplitude of intramyocardial electrocardiograms. Ann Thorac Surg 47:407–411.
Rossi S, Reale D, Grandi E (1991) Correlation of clinical diagnosis with autopsy findings. IARC Sci Publ, pp 99-108.
Rosskamm H, Reindell H (1989) Herzkrankheiten, 3. Auflage, Springer Verlag, Berlin Heidelberg New York, S 449.
Roth D, Milgrom M, Esquenazi V (1989) Posttransplant hyperglycemia. Transplantation 47:278–281.
Rowe SK, Kleiman NS, Cocanougher B (1991) Effects of intracoronary acetylcholine infusion early versus late after heart transplant. Transplant Proc 23:1193–1197.
Rubin RH (1994) Infection in the organ transplant recipient. In: Rubin K, Young LS (eds) Clinical Approach to Infection in the Compromised Host. Plenum, New York, pp 629–706.
Rubin RH, Tolkoff-Rubin NE (1999) Infection in the organ transplant recipient. In: Root RK, Waldvogel FA, Corey L, Stamm WE (eds) Clinical Infectious Diseases. Oxford University Press, New York, pp 821–828.
Rudas L, Pflugfelder PW, Kostuk WJ (1990) Comparison of hemodynamic responses during dynamic exercise in the upright and supine postures after orthotopic cardiac transplantation. J Am Coll Cardiol 16:1367–1373.
Salomon RN, Hughes CC, Schoen FJ, Payne DD, Pober JS, Libby P (1991) Human coronary transplantation-associated arteriosclerosis. Evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol 138:791–798.
Salter MM, Kirklin JK, Bourge RC, Nafel DC, White-Williams C, Tarkka M, Waits E, Bucy RP (1992) Total lymphoid irradiation in the treatment of early or recurrent heart rejection. J Heart Lung Transplant 11:902–912.
Samuels SI, Wyner J (1986) Anesthesia for surgery in patients with a transplanted heart. Br J Anaesth 58:1119.
Sanchez JA, Smith CR, Drusin RE, Reison DS, Mulm JR, Rose EA (1990) High risk reparative surgery: a neglected alternative to heart transplantation. Circulation 82 (suppl IV):302–305.
Sarris GE, Smith JA, Bernstein D, Griffin ML, Pitlick PT, Baum D, Billingham ME, Oyer BE, Stinson EB, Starnes VA, Shumway NE, Reitz BR (1994) Pediatric cardiac transplantation. The Stanford experience. Circulation 90 (part 2):51–55.
Saubolle MA, Kiehn TE, White MH, Rudinsky MF, Armstrong D (1996) Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev 9:435–447.
Savin WM, Haskell WL, Schroeder JS, Stinson EB (1980) Cardiorespiratory responses of cardiac transplant patients to graded, symptom-limited exercise. Circulation 62:55–60.
Sawa Y, Matsuda H, Shimazaki Y, Hirose H, Kadoba K, Takami H, Nakada T, Kawashima Y (1987) Ultrastructural assessment of the infant myocardium receiving crystalloid cardioplegia. Circulation 76:V141–145.
Saxon LA, Stevenson WG, Middlekauf HR, Fonarow G, Woo M, Moser D, Stevenson LW (1993) Predicting death from progressive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 72:62–65.
Scheidt von W, Kemkes BM, Reichart B (1993) Percutaneous transluminal coronary angioplasty of focal coronary lesions after transplantation. Clin Invest 71:524–530.
Scheid HH (1990) Herztransplantation: Münsteraner Protokoll. Universitätsverlag.
Scheid HH, Deng MC, Deiwick M, Roeder N (1996) Operationen bei eingeschränkter linksventrikulärer Pumpfunktion. Z Kardiol 85 (Suppl 6):287–301.
Scheid HH, Deng MC, Hammel D, Röder N, Rötker J (1994) Kosten-Nutzen-Relation in der Herz-Transplantation. Z Kardiol 83 (Suppl 6):139–149.
Scheid HH, Hammel D, Schmid C, Weyand M, Deng MC, Möllhoff Th, Kerber S (1996) Beating heart implantation of a wearable NOVACOR left-ventricular assist device. Thorac Cardiovasc Surgeon 44:62–66.
Scheid HH, Netz H, Bertram U (1989) Problematik der Herztransplantation im Kleinkind-und Neugeborenenalter. Z Herz Gefäßchir 3:59–61.
Scheid HH, Netz H, Moosdorf R, Bauer J, Görlach G (1990) Cardiac transplantation in infants. Vasc Surgery 24:592–597.
Scheid HH, Netz H, Moosdorf R, Bertram U, Bauer J, Stertmann WA, Fitz H, Becker HE (1989) Herztransplantation im Alter unter 2 Jahren. Med Welt 40:66–69.
Scheid HH, Soeparwata R, Schmid C, Loick M, Weyand M, Hammel D (1997) Rupture of inflow conduits in the TCI-HeartMate system. J Thorac Cardiovasc Surg 114(2):287–289.
Schmid C, Wahlers T, Schäfers H-J, Cremer J, Haverich A (1991) Schrittmacherimplantation nach orthotoper Herztransplantation: Inzidenz, Indikation und Ergebnisse. Herzschr Elektrophys 2:50–52.
Schmid C, Wahlers T, Schäfers H-J, Haverich A (1993) Supraventricular bradycardia after heart transplantation — orciprenaline or pacemaker implantation? Thorac Cardiovasc Surg 41:101–103.
Schmid C, Wahlers T, Jurmann M, Cremer J, Fieguth HG, Schäfers H-J, Haverich A (1993) Supraventricular bradycardia following heart transplantation necessitating pacemaker implantation — an analysis of possible underlying causes. Clin Transpl 7:147–150.
Schmid C, Heemann U, Azuma H, Tilney NL (1995) Transplant vasculopathy in rat heart transplantation: a morphologic chameleon determined by antigen-dependent and-independent factors. Transplant Proc 27:2077–2079.
Schmid C, Kerber S, Baba HA, Deng MC, Hammel D, Scheid HH (1997) Graft vascular disease after heart transplantation. Eur Heart J 18:554–559.
Schmid C, Deng MC, Hammel D, Weyand M, Loick HM, Scheid HH (1998) Emergency versus elective/urgent left ventricular assist device implantation. J Heart Lung Transplant 17:1024–1028.
Schmid C, Weyand M, Hammel D, Deng MC, Nabavi D, Scheid HH (1998) Effect of platelet inhibitors on thromboembolism after implantation of a Novacor N100 — preliminary results. Thorac Cardiovasc Surg 46(5):260–262.
Schmid C, Weyand M, Nabavi DG, Hammel D, Deng MC, Ringelstein EB, Scheid HH (1998) Cerebral and systemic embolization during left ventricular support with the Novacor N100 device. Ann Thorac Surg 65:1703–1710.
Schmid C, Deng MC, Gradaus R, Kley S, Breithardt G, Scheid HH (1999) Impact of local donor and regionalization on a German transplantation center. UNI NRW. Universities of North Rhine Westfalia. Transpl Int 12(2):141–144.
Schmid C, Hammel D, Deng MC, Weyand M, Baba H, Tjan TD, Drees G, Roeder N, Schmidt C, Scheid HH (1999) Ambulatory care of patients with left ventricular assist devices. Circulation 100(19 Suppl):II224–228.
Schmid C, Wilhelm M, Rothenburger M, Nabavi D, Deng MC, Hammel D, Scheid HH (2000) Effect of high dose platelet inhibitor treatment on thromboembolism in Novacor patients. Eur J Cardiothorac Surg 17:331–335.
Schowengærdt K, Ballantyne CM (1994) Key references on transplant coronary artery disease. Circulation 90:632–635.
Schowengeardt KO Jr, Towbin JA (1995) Genetic basis of inherited cardiomyopathies. Curr Opin Cardiol 10:312–321.
Schroeder JS (1979) Hemodynamic performance of the human transplanted heart. Transplant Proc 11:304–308.
Schroeder JS, Gao SZ, Alderman EL, Hunt SA, Johnstone I, Boothroyd DB, Wiederhold V, Stinson EB (1993) A preliminary study of diltiazem in the prevention of coronary artery disease in heart transplant recipients. N Engl J Med 328:164–170.
Schütz A, Kemkes BM, Breuer M (1992) Kinetics and dynamics of acute rejection after heterotopic heart transplantation. J Heart Lung Transplant 11:289–299.
Schwaiger M (1996) Indications for clinical applications of positron emission tomography in cardiology. Position report of the PET Cardiology Study Group of the German Society of Nuclear Medicine and the Nuclear Cardiology Study Circle of the German Society of Cardiology. Z Kardiol 85:453–468.
Seguchi M, Jarmakani JM, George BL, Harding JA (1986) Effect of Ca2+ antagonists on mechanical function in the neonatal heart. Pediatr Res 20:838–842.
Shapiro PA, Koenfeld DS (1989) Psychiatric outcome of heart transplantation. Gen Hosp Psychiatr 11:352–357.
Sharpies LD, Caine N, Mullins P, Scott JP, Solis E, English TAH, Large SR, Schofield PM, Wallwork J (1991) Risk factor analysis for the major hazards following heart transplantation — rejection, infection, and coronary occlusive disease. Transplantation 52:244–252.
Shelton ME, Senneff MJ, Ludbrook PA, Sobel BE, Bergmann SR (1993) Concordance of nutritive myocardial perfusion reserve and flow velocity reserve in conductance vessels in patients with chest pain with angiographically normal coronary arteries. J Nucl Med 34:717–722.
Siegel RJ, Shah PK, Fishbein MC (1984) Idiopathic restrictive cardiomyopathy. Circulation 70:165–169.
Sielaff TD, Everett JE, Shumway SJ, Wahoff DC, Bolman RM III, Dunn DL (1996) Mycoplasma hominis infections occurring in cardiovascular surgical patients. Ann Thorac Surg 61:99–103.
Singer MT (1981) Vietnam prisoners of war, stress and personality resiliency (editorial). Am J Psychiatr 138:345–346.
Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, Massie BM, Colling C, Lazzari D, for the Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure (1995) Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 333:77–88.
Smart FW, Ballantyne CM, Cocanougher B, Farmer JA, Sekela ME, Noon GP, Young JB (1991) Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant. Am J Cardiol 67:243–247.
Smart FW, Naftel DC, Costanzo MR, Levine TB, Pelletier GB, Yancy CW Jr, Hobbs RE, Kirklin JK, Bourge RC (1996) Risk factors for early, cumulative, and fatal infections after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 15:329–341.
Smith W (1985) Epidemiology of congestive heart failure. Am J Cardiol 55:3A–8A.
Smith TJ, Kyle RA, Lie JT (1984) Clinical significance of histopathologic patterns of cardiac amyloidosis. Mayo Clin Proc 59:547–555.
Solomon SD, Geisterfer Lawrance AA, Vosberg HP, Hiller G, Jarcho JA, Morton CC, McBride WO, Mitchell AL, Bale AE, McKenna WJ (1990) A locus for familial hypertrophic cardiomyopathy is closely linked to the cardiac myosin heavy chain genes, CRI-L436 and CRI-L329, on chromosome 14 at q11-q12. Am J Hum Genet 47:389–394.
SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 325:294–302.
Speir E, Modali R, Huang ES, Leon MB, Shawl F, Finkel T, Epstein SE (1994) Potential role of human cytomegalovirus and p53 interaction in coronary restenosis [see comments]. Science 265:391–394.
Spiegelhalter DJ, Stovin PG (1983) An analysis of repeated biopsies following cardiac transplantation. Stat Med 2:33–40.
Spratt P, Sivathasan C, Macdonald P, Keogh A, Chang V (1991) Role of routine endomyocardial biopsy to monitor late rejection after heart transplantation. J Heart Lung Transplant 10:912–914.
St. Goar FG, Pinto FJ, Alderman EL (1992) Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of “angiographically silent“ intimai thickening. Circulation 85:979–987.
Stark RP, McGinn AL, Wilson RF (1991) Chest pain in cardiac transplant recipients. N Eng J Med 324:1791–1794.
Starnes VA, Hammon JW Jr (1981) The influence of acute global ischemia on left ventricular compliance in the adult and immature dog. J Surg Res 30:281–286.
Starnes VA, Stinson EB, Oyer PE, Valantine H, Baldwin JC, Hunt SA, Shumway NE (1987) Cardiac transplantation in children and adolescents. Circulation 76:V43–47.
Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92:1355–1374.
Starzl TE, Nalesnik MA, Porter KA, Ho M, Iwatsuki S, Griffith BP, Rosenthal JT, Hakala TR, Shaw BW Jr, Hardesty RL (1984) Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet 1:583–587.
Starzl TE, Todo S, Fung J, Demetris AJ, Venkataramanan R, Jain A (1989) FK 506 for liver, kidney, and pancreas transplantation. Lancet 2:1000–1004.
Stevenson LW, Belil D, Grover-McKay M, Brunken RC, Schwaiger M, Tillisch JH, Schelbert HR (1987) Effects of afterload reduction on left ventricular volume and mitral regurgitation in severe congestive heart failure. Am J Cardiol 60: 654–658.
Stevenson LW, Hamilton MA, Tillisch JH, Moriguchi JD, Kobashigawa JA, Creaser JA, Drinkwater DC, Laks H (1991) Decreasing survival benefit from cardiac transplantation for outpatients as the waiting list lengthens. J Am Coll Cardiol 18:919–925.
Stevenson LW, Miller LW (eds) (1991) Cardiac transplantation as therapy for heart failure. Curr Probl Cardiol 4:229–305.
Stevenson LW, Sietsema K, Tillisch JH, Lern V, Waiden J, Kobashigawa JA, Moriguchi J (1990) Exercise capacity for survivors of cardiac transplantation or sustained medical therapy for stable heart failure. Circulation 81:78–85.
Stevenson LW, Steimle AE, Fonarow G, Kermani M, Kermani D, Hamilton MA, Moriguchi JD, Waiden J, Tillisch JH, Drinkwater DC, Laks H (1995) Improvement in exercise capacity of candidates awaiting heart transplantation. J Am Coll Cardiol 25:163–170.
Stevenson LW, Tillisch JH, Hamilton MA, Lau M, Chelirnsky-Follick C, Moriguchi J, Waiden J (1990) Importance of hemodynamic response to therapy in predicting survival with ejection factor <20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 6:1348–1354.
Stevenson LW (1991) Tailored therapy before transplantation for treatment of advanced heart failure: effective use of vasocilators and diuretics. J Heart Lung Transplant 10:468–476.
Stevenson LW (1996) Selection and management of candidates for heart transplantation. Curr Opin Cardiol 11:166–173.
Stinson EB, Bieber CP, Griepp RB, Clark DA, Shumway NE, Remington JS (1971) Infectious complications after cardiac transplantation in man. Ann Intern Med 74:22–36.
Stinson EB, Caves PK, Stiff JL (1975) Hemodynamic observations in the early period after human heart transplantation. J Thorac Cardiovasc Surg 69:264–270.
Swedberg K (1987) Use of nitrates in acute and chronic congestive heart failure. Drugs 33 (Suppl 4):147–149.
Tai PC, Ackerman SJ, Spry CJ, Dunnette S, Olsen EG, Gleich GJ (1987) Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1:643–647.
Tandler R, Schmid C, Weyand M, Scheid HH (1997) Novacor LVAD bridge to transplantation in peripartum cardiomyopathy. Eur J Cardiothor Surg 11:394–396.
Thaler SJ, Rubin RH (1996) Opportunistic infections in the cardiac transplant patient. Curr Opin Cardiol 11:191–203.
The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325:293–302.
Thiene G, Nava A, Corrado D, Rossi L, Pennelli N (1988) Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 318:129–133.
Thiene G, Corrado D, Nava A, Rossi L, Poletti A, Boffa GM, Daliento L, Pennelli N (1991) Right ventricular cardiomyopathy: is there evidence of an inflammatory aetiology? Eur Heart J 12 (suppl D).
Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, Seidman JG, Seidman CE (1994) Alphatropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: a disease of the sarcomere. Cell 77:701–712.
Thompson AW, Starzl TE (eds) (1994) Immunosuppressive drugs. Developments in anti-rejection therapy. Arnold, Boston.
Thompson ME (ed) (1990) Cardiac transplantation. Davis, Philadelphia.
Thompson ME, Shapiro AP, Johnson AM (1986) The contrasting effect of cyclosporine A and azathioprine on arterial blood pressure and renal function following cardiac transplantation. Int J Cardiol 11:219–229.
Tjan TDT, Schmid C, Deng MC, Schmidt C, Kerber S, Kehl G, Scheid HH (1999) Evolving short-term and long-term mechanical assist for cardiac failure — a decade experience in Muenster. Thorac Cardiovasc Surg 47 (suppl):294–297.
Tsutamoto T, Hisanaga T, Wada A, Maeda K, Ohnishi M, Fukai D, Mabuchi N, Sawaki M, Kinoshita M (1998) Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important predictor in patients with congestive heart failure. J Am Coll Cardiol 31:391–398.
Unverfehrt DV, Magorien RD, Moeschberger ML (1984) Factors influencing the 1-year-mortality of dilated cardiomyopathy. Am J Cardiol 4:147–152.
Uretsky BF, Murali S, Reddy PS (1987) Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 76:827–834.
Uzark KC, Sauer SN, Lawrence KS, Miller J, Addonizio L, Crowley DC (1992) The psychosocial impact of pediatric heart transplantation. J Heart Lung Transplant 11:1160–1167.
Valantine HA, Keogh A, McIntosh N, Hunt SA, Oyer P, Schroeder J (1992) Cost containment: coadministration of diltiazem with cyclosporine after heart transplantation. J Heart Transplant 11:1–8.
Valantine HA (1993) Rejection surveillance by Doppler echocardiography (editorial). J Heart Lung Transplant 12:422–426.
Valantine HA, Schroeder JS (1995) Recent advances in cardiac transplantation. N Engl J Med 333:660–661.
Wagner FM, Reichenspurner H, Überfuhr P, Weiss M, Fingerle V, Reichart B (1994) Toxoplasmosis after heart transplantation: diagnosis by endomyocardial biopsy. J Heart Lung Transplant 13:916–918.
Wald RW, Waxman MB, Coney PN, Gunstensen J, Goldman BS (1979) Management of intractable ventricular tachycardia after myocardial infarction. Am J Cardiol 44:329–338.
Warnecke H, Schüler S, Goetze HJ (1986) Non-invasive monitoring of cardiac allograft rejection by intramyocardial electrogram recordings. Circulation 74 (suppl III):72.
Warnecke H, Müller J, Cohnert T, Hummel M, Spiegelsberger S, Siniawski H, Lieback E, Hetzer R (1992) Clinical heart transplantation without routine endomyocardial biopsy. J Heart Lung Transplant 11:1093–1102.
Watts D (1984) Psychiatric aspects of cardiac transplantation. I Heart Transplant 3:243–247.
Wechsler AS, Abd-Elfattah AS, Murphy CE, Salter DR, Brunsting LA, Goldstein JP (1986) Myocardial protection. J Card Surg 1:271–306.
Weis M, Scheidt WV (1997) Cardiac allograft vasculopathy. A review. Circulation 96:2067–2077.
Weis M, Hartmann A, Olbrich HG, Hör G, Zeiher AM (1998) Prognostic significance of coronary flow reserve on left ventricular ejection fraction in cardiac transplant recipients. Transplantation 65:103–108.
Weyand M, Kececioglu D, Kehl HG, Schmid C, Loick HM, Vogt J, Scheid HH (1998) Neonatal mechanical bridging to total orthotopic heart transplantation. Ann Thorac Surg 66:519–522.
Wichter T, Hindricks G, Lerch H, Bartenstein P, Borggrefe M, Schober O, Breithardt G (1994) Regional myocardial sympathetic dysinnervation in ar-rhythmogenic right ventricular cardiomyopathy. An analysis using 1231-metaiodobenzylguanidine scintigraphy. Circulation 89:667–683.
Wieselthaler GM, Schima H, Hiesmayr M, Pacher R, Laufer G, Noon GP, DeBakey M, Wolner E (2000) First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation. Circulation 101(4):356–359.
Williams BAH, Grady KL, Sandiford-Guttenbeil DM (1991) Organ transplantation: a manual for nurses. Springer, New York.
Wilson JR, Schwartz JS, St. John Sutton M, Ferraro N, Horowitz LN, Reichek N, Josephson ME (1983) Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopy activity. J Am Coll Cardiol 2:403–409.
Winters GL, Schoen FJ (1997) Graft arteriosclerosis-induced myocardial pathology in heart transplant recipients: predictive value of endomyocardial biopsy. J Heart Lung Transplant 16:985–993.
Wissenschaftlicher Beirat der Bundesärztekammer (1993) Der endgültige Ausfall der gesamten Hirnfunktion („Hirntod“) als sicheres Todeszeichen. Dt Ärztebl 90:Al–2933-2935.
Witteis E, Hay J, Gotto A (1990) Medical cost of coronary artery disease in the United States. Am J Cardiol 65:432–440.
Wyner J, Finch EL (1987) Heart and Lung Transplantation. In: Gelman S (ed) Anesthesia and Organ Transplantation. Saunders, Philadelphia, pp 111–137.
Yeatman M, Smith JA, Dunning JJ, Large SR, Wallwork J (1995) Cardiac transplantation. A review. Cardiovasc Surg 3:1–14.
York LJ, Qualtiere LF (1990) Cyclosporin abrogates virus-specific T-cell control of EBV-induced B-cell lymphoproliferation. Viral Immunol 3:127–136.
Young JB, Winters WLJ, Bourge R, Uretsky BF (1993) 24th Bethesda Conference (Task Force 4): Function of the heart transplant recipient. J Am Coll Cardiol 22:31–41.
Young HH, Shimizu T, Nishioka K, Nakanishi T, Jarmakani JM (1983) Effect of hypoxia and reoxygenation on mitochondrial function in neonatal myocardium. Am J Physiol 245:H998–1006.
Yusuf S, Theodoropoulos S, Mathias CJ (1987) Increased sensitivity of the denervated transplanted human heart to isoprenaline both before and after β-adrenergic blockade. Circulation 75:696–704.
Zales VR, Stapleton PL (1993) Neonatal and infant heart transplantation. Ped Clin North Am 40 (5):1023–1046.
Zales VR, Wright KL, Pahl E, Backer CL, Mavroudis C, Muster AJ, Benson DW (1994) Normal left ventricular muscle mass and mass/volume ratio after pediatric cardiac transplantation. Circulation 90 (part 2):61–65.
Zerkowski HR, Erhard J (1994) Herz-und Nierentransplantation. In: Brass H, Philipp T, Schulz W (Hrsg) Manuale Nephrologicum. Dustri XI-15:1–8.
Zerkowski HR, Schüler S, Mohr FW, Teichmann W, Schuler G, Lilie H (1997) Regionalisierung der Herztransplantation. Dt Ärztebl 94:A–2397-2398.
Zimmermann R (für die AG Thorakale Organtransplantation der DGK) (1996) Herztransplantation: Nachsorge und Rehabilitation. Derzeitiger Stand und Ergebnisse einer Umfrage bei deutschen Transplantationsprogrammen. Z Kardiol 85:67–77.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Scheld, H.H., Hammel, D., Deng, M.C., Schmid, C. (2001). Literatur. In: Leitfaden Herztransplantation. Steinkopff, Heidelberg. https://doi.org/10.1007/978-3-662-12257-0_18
Download citation
DOI: https://doi.org/10.1007/978-3-662-12257-0_18
Publisher Name: Steinkopff, Heidelberg
Print ISBN: 978-3-7985-1224-5
Online ISBN: 978-3-662-12257-0
eBook Packages: Springer Book Archive